Experts zero in on key protein in search for coronavirus treatment

03/13/2013 | Bloomberg Businessweek

A new coronavirus that has infected at least 15 people and killed nine in the past year adheres to the DPP4 cell-surface protein, but diabetes drugs that block the protein aren't effective in stopping the virus, and existing antibodies that block the virus also kill somatic cells, according to new research. It is possible the drugs tested on the virus do not block the portion of the protein where the pathogen adheres, so future research will look more deeply into how the virus attaches. Scientists are also testing a potential vaccine, but it would not be available to humans anytime soon.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park